Pitt Shield

Ultrasound and the blood-brain barrier.

Authors: Patrick JT, Nolting MN, Goss SA, Dines KA, Clendenon JL, Rea MA, Heimburger RF

High intensity focused ultrasound was employed to modify the permeability of the normal feline and canine blood-brain barrier (BBB) to a circulating vital dye--Evans blue (EB). The threshold doses (W sec/cm2) for focally increasing the permeability of the BBB in white matter (WM) and gray matter (GM) were as follows: internal capsule (WM)--340 to 680; thalamus (GM)--approximately 1326; and caudate nucleus (GM)--2284 to 2952. In the presence of supralesioning doses of ultrasound, the cross sectional area occupied by the EB was consistently greater than that of the attendant nonhemorrhagic lesion--thus suggesting that BBB changes may be inducible at sublesioning doses. These findings, in conjunction with those of others, suggest that high intensity focused ultrasound may have a role in the treatment of brain tumors based on cell destruction by two mechanisms: (a) direct, by the ultrasound and (b) indirect, by an antineoplastic agent which is delivered via an ultrasonically modified BBB.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To investigate how ultrasound can be used to transiently open the blood–brain barrier to enable therapeutic delivery to the brain.

Outcomes and Safety

Summary of Outcomes No experimental details or outcomes are present in the provided text beyond the paper title, so biological/behavioral effects and any successful focused ultrasound parameters cannot be determined.
Safety-related matter The provided text contains only the title and no mentions of safety or adverse effects; no safety-related information is present.

Brain Region

Visualization unavailable

Ultrasound Parameters

Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search